Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Chubb
Boehringer Ingelheim
McKinsey
Mallinckrodt
Chinese Patent Office
Colorcon
Accenture

Generated: May 21, 2018

DrugPatentWatch Database Preview

Mecamylamine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for mecamylamine hydrochloride and what is the scope of mecamylamine hydrochloride patent protection?

Mecamylamine hydrochloride
is the generic ingredient in two branded drugs marketed by Targacept and Nexgen Pharma, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for mecamylamine hydrochloride. Three suppliers are listed for this compound.
Summary for mecamylamine hydrochloride
Pharmacology for mecamylamine hydrochloride
Medical Subject Heading (MeSH) Categories for mecamylamine hydrochloride

US Patents and Regulatory Information for mecamylamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Targacept INVERSINE mecamylamine hydrochloride TABLET;ORAL 010251-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nexgen Pharma MECAMYLAMINE HYDROCHLORIDE mecamylamine hydrochloride TABLET;ORAL 204054-001 Mar 19, 2013 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Johnson and Johnson
Mallinckrodt
Colorcon
Boehringer Ingelheim
Daiichi Sankyo
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.